1. Home
  2. HUCK vs CDXS Comparison

HUCK vs CDXS Comparison

Compare HUCK & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huckleberry.ai Inc. Class B Common Stock

HUCK

Huckleberry.ai Inc. Class B Common Stock

N/A

Current Price

$2.75

Market Cap

129.3M

Sector

Technology

ML Signal

N/A

Logo Codexis Inc.

CDXS

Codexis Inc.

N/A

Current Price

$1.08

Market Cap

154.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
HUCK
CDXS
Founded
2010
2002
Country
United States
United States
Employees
876
N/A
Industry
Computer Software: Prepackaged Software
Major Chemicals
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
129.3M
154.4M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
HUCK
CDXS
Price
$2.75
$1.08
Analyst Decision
Hold
Buy
Analyst Count
2
8
Target Price
$4.17
★ $6.14
AVG Volume (30 Days)
681.7K
★ 846.3K
Earning Date
12-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
★ 43.82
EPS
N/A
★ N/A
Revenue
★ $318,857,000.00
$138,590,000.00
Revenue This Year
N/A
$4.97
Revenue Next Year
$1.33
$18.69
P/E Ratio
★ N/A
N/A
Revenue Growth
0.57
★ 32.30
52 Week Low
$2.96
$0.96
52 Week High
$3.55
$2.98

Technical Indicators

Market Signals
Indicator
HUCK
CDXS
Relative Strength Index (RSI) 27.09 36.20
Support Level N/A $0.96
Resistance Level $3.22 $1.24
Average True Range (ATR) 0.13 0.08
MACD -0.02 -0.02
Stochastic Oscillator 8.00 23.53

Price Performance

Historical Comparison
HUCK
CDXS

About HUCK Huckleberry.ai Inc. Class B Common Stock

Huckleberry.ai Inc, formerly Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: